199 related articles for article (PubMed ID: 35305687)
1. Efficacy of immunonutritional supplement after neoadjuvant chemotherapy in patients with esophageal cancer.
Luo C; Xie K; Zhang C; Cong ZZ; Gu WF; Xu Y; Qiang Y; Li XK; Zheng C; Hu LW; Shen Y
J Cardiothorac Surg; 2022 Mar; 17(1):41. PubMed ID: 35305687
[TBL] [Abstract][Full Text] [Related]
2. Enteral immunonutrition versus enteral nutrition for patients undergoing esophagectomy: a randomized controlled trial.
Li XK; Cong ZZ; Wu WJ; Xu Y; Zhou H; Wang GM; Qiang Y; Luo LG; Shen Y
Ann Palliat Med; 2021 Feb; 10(2):1351-1361. PubMed ID: 33222455
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of perioperative immunonutrition in esophageal cancer patients undergoing esophagectomy.
Kanekiyo S; Takeda S; Iida M; Nishiyama M; Kitahara M; Shindo Y; Tokumitsu Y; Tomochika S; Tsunedomi R; Suzuki N; Abe T; Yoshino S; Hazama S; Ueno T; Nagano H
Nutrition; 2019 Mar; 59():96-102. PubMed ID: 30468936
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of the prognostic nutritional index in esophageal cancer patients undergoing neoadjuvant chemotherapy.
Nakatani M; Migita K; Matsumoto S; Wakatsuki K; Ito M; Nakade H; Kunishige T; Kitano M; Kanehiro H
Dis Esophagus; 2017 Aug; 30(8):1-7. PubMed ID: 28575242
[TBL] [Abstract][Full Text] [Related]
5. Influence of Neoadjuvant Chemotherapy on Short-term Outcomes After Minimally Invasive Esophagectomy for Esophageal Cancer.
Nomoto D; Yoshida N; Akiyama T; Kiyozumi Y; Eto K; Hiyoshi Y; Nagai Y; Iwatsuki M; Iwagami S; Baba Y; Miyamoto Y; Baba H
Anticancer Res; 2019 Jan; 39(1):471-475. PubMed ID: 30591497
[TBL] [Abstract][Full Text] [Related]
6. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
[TBL] [Abstract][Full Text] [Related]
7. Network meta-analysis of the optimal time of applying enteral immunonutrition in esophageal cancer patients receiving esophagectomy.
Tian X; Jin YF; Liu XL; Chen H; Chen WQ; Jiménez-Herrera MF
Support Care Cancer; 2022 Sep; 30(9):7133-7146. PubMed ID: 35445866
[TBL] [Abstract][Full Text] [Related]
8. Safety and feasibility of esophagectomy following combined neoadjuvant immunotherapy and chemotherapy for locally advanced esophageal cancer: a propensity score matching.
Hong ZN; Zhang Z; Chen Z; Weng K; Peng K; Lin J; Kang M
Esophagus; 2022 Apr; 19(2):224-232. PubMed ID: 34988773
[TBL] [Abstract][Full Text] [Related]
9. Perioperative enteral immunonutrition with probiotics favors the nutritional, inflammatory, and functional statuses in digestive system surgery.
Huang Z; Wang Y
Asia Pac J Clin Nutr; 2022 Mar; 31(1):78-86. PubMed ID: 35357106
[TBL] [Abstract][Full Text] [Related]
10. Nutritional optimization during neoadjuvant therapy prior to surgical resection of esophageal cancer-a narrative review.
Huddy JR; Huddy FMS; Markar SR; Tucker O
Dis Esophagus; 2018 Jan; 31(1):1-11. PubMed ID: 29024949
[TBL] [Abstract][Full Text] [Related]
11. Does neoadjuvant therapy for esophageal cancer increase postoperative morbidity or mortality?
Mungo B; Molena D; Stem M; Yang SC; Battafarano RJ; Brock MV; Lidor AO
Dis Esophagus; 2015 Oct; 28(7):644-51. PubMed ID: 25059343
[TBL] [Abstract][Full Text] [Related]
12. Effects of preoperative nutrition on postoperative outcomes in esophageal cancer: a systematic review and meta-analysis.
Cao Y; Han D; Zhou X; Han Y; Zhang Y; Li H
Dis Esophagus; 2022 Mar; 35(3):. PubMed ID: 33969399
[TBL] [Abstract][Full Text] [Related]
13. Safety analysis of early oral feeding after esophagectomy in patients complicated with diabetes.
Jiang Z; Luo J; Xu M; Cong Z; Ji S; Diao Y; Xu Y; Shen Y
J Cardiothorac Surg; 2021 Mar; 16(1):56. PubMed ID: 33771195
[TBL] [Abstract][Full Text] [Related]
14. Effect of Enteral Immunonutrition in Patients Undergoing Surgery for Gastrointestinal Cancer: An Updated Systematic Review and Meta-Analysis.
Shen J; Dai S; Li Z; Dai W; Hong J; Huang J; Chen J
Front Nutr; 2022; 9():941975. PubMed ID: 35845793
[TBL] [Abstract][Full Text] [Related]
15. Enteral immunonutrition versus enteral nutrition for patients undergoing oesophagectomy: a systematic review and meta-analysis.
Li XK; Zhou H; Xu Y; Cong ZZ; Wu WJ; Luo J; Jiang ZS; Shen Y
Interact Cardiovasc Thorac Surg; 2020 Jun; 30(6):854-862. PubMed ID: 32206808
[TBL] [Abstract][Full Text] [Related]
16. [Clinical outcomes of thoracoscopic esophagectomy after neoadjuvant chemotherapy].
Takemura M; Kaibe N; Yamashita H; Takii M; Hori T; Oshima T; Kikuchi S; Sasako M
Gan To Kagaku Ryoho; 2013 Nov; 40(12):1609-11. PubMed ID: 24393864
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of thoracoscopic esophagectomy after neoadjuvant chemotherapy.
Tanaka E; Okabe H; Tsunoda S; Obama K; Kan T; Kadokawa Y; Akagami M; Sakai Y
Asian J Endosc Surg; 2012 Aug; 5(3):111-7. PubMed ID: 22776501
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic ultrasound: doubtful accuracy for restaging esophageal cancer after preoperative chemotherapy.
Machlenkin S; Melzer E; Idelevich E; Ziv-Sokolovsky N; Klein Y; Kashtan H
Isr Med Assoc J; 2009 Mar; 11(3):166-9. PubMed ID: 19544707
[TBL] [Abstract][Full Text] [Related]
19. Randomized controlled trial on efficacy of oligomeric formula (HINE E-GEL®) versus polymeric formula (MEIN®) enteral nutrition after esophagectomy for esophageal cancer with gastric tube reconstruction.
Ohkura Y; Ueno M; Shindoh J; Iizuka T; Udagawa H
Dis Esophagus; 2019 May; 32(5):. PubMed ID: 30169605
[TBL] [Abstract][Full Text] [Related]
20. Thromboembolic events before esophagectomy for esophageal cancer do not result in worse outcomes.
Teman NR; Silski L; Zhao L; Kober M; Urba SC; Orringer MB; Chang AC; Lin J; Reddy RM
Ann Thorac Surg; 2012 Oct; 94(4):1118-24; discussion 1124-5. PubMed ID: 22858275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
